Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dimethyl fumarate protection against collagen II degradation.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Charcot-Marie-Tooth 1A: a narrative review with clinical and anatomical perspectives.
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
CombiRx for MS not better than monotherapy
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Neuro-Immune Interactions at Barrier Surfaces.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis ((DECIDE))

Pages